On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study - Top-Institutions - MDSpire

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

  • By

  • Ryo Nakano

  • Ayumi Ichisawa

  • Kenya Saruta

  • Masakazu Kogawa

  • Akira Fukuda

  • June 17, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mutsu General Hospital
    Mutsu General Hospital

    Mutsu, Aomori

    Key Differentiators

    • Endocrinology

  • #2

    Shimokita Medical Center Association
    Shimokita Medical Center Association

    Shimokita, Aomori

    Key Differentiators

    • Endocrinology

  • #3

    Oulu University Hospital
    Oulu University Hospital

    Oulu, Oulu

    Key Differentiators

    • Endocrinology

  • #4

    Reference Centre of Rare Bone Diseases
    Reference Centre of Rare Bone Diseases

    Not specified, Not specified

    Key Differentiators

    • Endocrinology

Original Source(s)

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

  • by Ryo Nakano, Ayumi Ichisawa, Kenya Saruta, Masakazu Kogawa, Akira Fukuda

  • June 17, 2026

Related Content

Association of Bone Mass, Falls, and Vertebral Fractures in Older Patients on Hemodialysis: The Role of Comprehensive Geriatric Assessment

Restorative Management of Constriction and Spacing Following Arch Expansion

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.